VISTN logo

Vistin Pharma ASA Stock Price

OB:VISTN Community·NOK 957.8m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 1 Fair Values set on narratives written by author

VISTN Share Price Performance

NOK 21.60
-2.30 (-9.62%)
NOK 21.60
-2.30 (-9.62%)
Price NOK 21.60

VISTN Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Flawless balance sheet with solid track record.

2 Risks
2 Rewards

Vistin Pharma ASA Key Details

NOK 452.3m

Revenue

NOK 151.5m

Cost of Revenue

NOK 300.8m

Gross Profit

NOK 226.0m

Other Expenses

NOK 74.8m

Earnings

Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
Apr 24, 2026
1.69
66.50%
16.53%
0%
View Full Analysis

About VISTN

Founded
1969
Employees
73
CEO
Magnus Tolleshaug
WebsiteView website
www.vistin.com

Vistin Pharma ASA, through its subsidiary, Vistin Pharma AS, engages in the production and sale of active pharmaceutical ingredients (APIs) worldwide. It offers metformin HCl APIs and direct compressive granulates for the pharmaceutical industry. The company was founded in 1969 and is based in Oslo, Norway.

Recent VISTN News & Updates

Recent updates

No updates

Vistin Pharma ASA Competitors